子宫内膜癌患者来源外植体、异种移植与类器官:三维患者相关临床前模型
综述总结了子宫内膜癌中可保留肿瘤微环境与肿瘤-间质相互作用的三维患者相关临床前模型,包括球体、患者来源类器官、微流控系统、患者来源异种移植和患者来源外植体,重点阐述患者来源外植体平台的优势、局限及转化研究应用。
要点
- 晚期子宫内膜癌化疗应答率和总生存仍差,且患者多为老年合并症多,亟需优化治疗策略并个体化治疗。
- 三维模型可保留肿瘤微环境和肿瘤-间质相互作用,对免疫治疗和分子靶向药物的转化研究日益重要。
- 患者来源外植体平台是本文重点阐述的三维模型系统,具有转化研究应用潜力。
核心结论
- 晚期子宫内膜癌化疗应答率和总生存仍差,老年合并症多的患者接受强力细胞毒治疗可能有危险,亟需确定晚期和复发疾病的最佳治疗策略并基于个体肿瘤和患者特征进行个体化治疗。
研究设计与样本
- 本文为综述,总结子宫内膜癌可用的三维建模系统,包括球体、患者来源类器官、微流控系统、患者来源异种移植和患者来源外植体。
主要发现
- 三维患者相关临床前模型可保留肿瘤微环境和肿瘤-间质相互作用,在免疫治疗和分子靶向药物转化研究中日益重要。
- 本文重点阐述患者来源外植体平台的当前使用、优势、劣势及转化研究应用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The majority of endometrial cancers are detected early with a favourable prognosis. However, for patients with advanced disease, chemotherapy response rates and overall survival remains poor. The endometrial cancer population is typically elderly with multiple co-morbidities and aggressive cytotoxic therapy may be hazardous. Therefore, there is an urgent need to define optimal treatment strategies for advanced and recurrent disease and personalise therapy based on individual tumour and patient characteristics. Three-dimensional (3D) models that preserve the tumour microenvironment and tumour-stromal interactions are increasingly important for translational research with the advent of immunotherapy and molecularly targeted agents. 3D patient-relevant pre-clinical models in endometrial cancer include spheroids, patient-derived organoids, microfluidic systems, patient-derived xenografts and patient-derived explants. Here we present a review of available 3D modelling systems in endometrial cancers, highlighting their current use, advantages, disadvantages and applications to translational research with a focus on the power of the patient-derived explant platform.
引用
- Collins A, Miles GJ, Wood J, et al. Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer. Gynecol Oncol. 2019. PMID: 31767187. doi:10.1016/j.ygyno.2019.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。